Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S469000, C514S272000
Reexamination Certificate
active
08003673
ABSTRACT:
Daptomycin can be used for biofilm treatment (particularly central venous catheter salvage forS. epidermidisinfected catheters). Catheter salvage with daptomycin shows rapid cidality, activity against stationary phase bacteria, and penetration and activity in biofilms. The present inventions provide formulations, methods, and articles of manufacture useful for biofilm treatment or catheter salvage involving daptomycin. Particular formulations include daptomycin in lactated Ringer's solution having a rapid kill curve against the bacteria of the biofilm.
REFERENCES:
patent: 6777420 (2004-08-01), Zhi et al.
Cubicin® (daptomycin for injection) Label 1004—Sep. 2003.
Cubicin® (daptomycin for injection) Label 1004-1—Revised Aug. 2004.
Cubicin® (daptomycin for injection) Label 1004-2—Revised Jun. 2005.
Alder Jeffrey
Mortin Lawrence
Silverman Jared
Van Praagh Andrew
Cubist Pharmaceuticals, Inc.
Cubist Pharmaceuticals, Inc.
Ward Paul V.
LandOfFree
Daptomycin for the treatment of biofilm and catheter salvage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Daptomycin for the treatment of biofilm and catheter salvage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Daptomycin for the treatment of biofilm and catheter salvage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656753